Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Watson Pharmaceuticals, Inc. : Watson to Present at the Citi 2012 Global Healthcare Conference

02/16/2012| 04:05pm US/Eastern
Recommend:
0

PARSIPPANY, N.J., Feb. 16, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Citi 2012 Global Healthcare Conference on Monday, February 27, 2012 at 11:30 am Eastern Time at The Waldorf Astoria in New York, New York. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL:

http://www.veracast.com/webcasts/citigroup/healthcare2012/55108485.cfm

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO )

    CONTACTS:                         Investors:
                                      Patty Eisenhaur
                                      (862) 261-8141

                                      Media:
                                      Charlie Mayr
                                      (862) 261-8030

SOURCE Watson Pharmaceuticals, Inc.

Recommend :
0
Partner Area
React to this article
 
Latest news on ACTAVIS INC
42m ago Asian markets sell off on Bernanke remarks, China PMI
3d agoDJMARKET SNAPSHOT: U.S. Stocks Drop, Retreating From All-time Highs
3d ago Actavis to buy Warner Chilcott in $5 billion stock deal
3d agoDJMARKET SNAPSHOT: U.S. Stocks Slip After Hitting All-time Highs
3d agoDJActavis to Buy Warner Chilcott for $5 Billion in Stock
3d agoDJMARKET SNAPSHOT: U.S. Stocks Grind Higher To All-time Highs
3d agoDJMARKET SNAPSHOT: U.S. Stocks Grind Higher To All-time Highs
3d agoDJActavis to Buy Warner Chilcott For $5 Billion in Stock
3d agoDJMARKET SNAPSHOT: U.S. Stocks Waver; Deal News, Fed In Focus
3d agoDJMARKET SNAPSHOT: U.S. Stocks Waver; Deal News, Fed In Focus
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.